中国全科医学2025，Vol.28Issue(30)：3747-3752,6.DOI:10.12114/j.issn.1007-9572.2025.0131
2024意大利《成人超重、肥胖和代谢合并症行为治疗抵抗的管理指南》解读与启示
Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment
摘要
Abstract
Obesity is frequently accompanied by metabolism-related diseases,serving as a critical etiological factor or risk factor and being associated with adverse clinical outcomes.Effective weight reduction has been demonstrated to ameliorate or even alleviate these comorbidities.However,lifestyle interventions alone often yield suboptimal efficacy,and behavioral resistance is often observed.In China,there are currently no specific guidelines targeting patients with behavioral resistance.In 2024,the Italian Association of Clinical Endocrinologists released the Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities that are Resistant to Behavioral Treatment,grounded in the latest evidence-based research.The guidelines primarily focus on pharmacological and surgical interventions in this patient population.This paper,in conjunction with Chinese guidelines,delves into the obesity evaluation and treatment strategies from the Italian guidelines,aiming to offer a reference for managing Chinese overweight or obese patients with behavioral resistance.关键词
肥胖管理/超重/代谢合并症/行为治疗抵抗/药物疗法/减重代谢手术Key words
Obesity management/Overweight/Metabolic comorbidities/Behavioral therapy resistance/Drug therapy/Metabolic-bariatric surgeries分类
医药卫生引用本文复制引用
张鹏,刘力滴,张颖,杨梓钰,刘长明,唐以俊,廖晓阳,贾禹..2024意大利《成人超重、肥胖和代谢合并症行为治疗抵抗的管理指南》解读与启示[J].中国全科医学,2025,28(30):3747-3752,6.基金项目
四川省科技厅软科学项目(2022JDR0325) （2022JDR0325）
